Raphael Pharmaceutical annual total assets
2020
2021
2022
2023
2024
2025
Raphael Pharmaceutical Total Assets Growth & History (RAPH)
Raphael Pharmaceutical's total assets was $53,000 for fiscal 2025.
View full Raphael Pharmaceutical company overviewRaphael Pharmaceutical annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $53,000 | $26,000 | +96.30% |
| 2024 | 2024-12-31 | $27,000 | −$212,000 | −88.70% |
| 2023 | 2023-12-31 | $239,000 | −$94,000 | −28.23% |
| 2022 | 2022-12-31 | $333,000 | −$89,000 | −21.09% |
| 2021 | 2021-12-31 | $422,000 | $99,000 | +30.65% |
| 2020 | 2020-12-31 | $323,000 | — | — |
Raphael Pharmaceutical quarterly total assets
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7,000 | −$23,000 | −76.67% |
| Q1 2026 | 2026-03-31 | $3,000 | −$90,000 | −96.77% |
| Q4 2025 | 2025-12-31 | $53,000 | $26,000 | +96.30% |
| Q3 2025 | 2025-09-30 | $7,000 | −$44,000 | −86.27% |
| Q2 2025 | 2025-06-30 | $30,000 | −$98,000 | −76.56% |
| Q1 2025 | 2025-03-31 | $93,000 | −$260,000 | −73.65% |
| Q4 2024 | 2024-12-31 | $27,000 | −$212,000 | −88.70% |
| Q3 2024 | 2024-09-30 | $51,000 | −$352,000 | −87.34% |
| Q2 2024 | 2024-06-30 | $128,000 | $9,000 | +7.56% |
| Q1 2024 | 2024-03-31 | $353,000 | $203,000 | +135.33% |
| Q4 2023 | 2023-12-31 | $239,000 | −$94,000 | −28.23% |
| Q3 2023 | 2023-09-30 | $403,000 | $282,000 | +233.06% |
| Q2 2023 | 2023-06-30 | $119,000 | −$77,000 | −39.29% |
| Q1 2023 | 2023-03-31 | $150,000 | −$30,000 | −16.67% |
| Q4 2022 | 2022-12-31 | $333,000 | −$89,000 | −21.09% |
| Q3 2022 | 2022-09-30 | $121,000 | $59,000 | +95.16% |
| Q2 2022 | 2022-06-30 | $196,000 | — | — |
| Q1 2022 | 2022-03-31 | $180,000 | — | — |
| Q4 2021 | 2021-12-31 | $422,000 | $99,000 | +30.65% |
| Q3 2021 | 2021-09-30 | $62,000 | — | — |
| Q4 2020 | 2020-12-31 | $323,000 | — | — |
Raphael Pharmaceutical total assets trends
Over the last five fiscal years, Raphael Pharmaceutical's total assets decreased from $323,000 to $53,000, a change of −$270,000. The latest reported quarter, Q2 2026, shows $7,000.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Raphael Pharmaceutical source filings ↗